LAG3 and breast cancer: Overall, these studies show that LAG3 expression in BC is associated with extensive immune infiltration and frequently associated with other immune checkpoint molecules (particularly PD-1/PD-L1), providing a strong rationale for targeting both LAG3 and PD-1/PD-L1 concurrently or sequentially.